Optimising Early Clinical Development Strategies in Oncology

Read how Aptus Clinical can help you navigate the drug development challenges in oncology to optimise your early clinical development strategy

Digital Involvement

Steve talks about digital involvement in clinical research: the area is highly regulated, the use of digital technology data in supporting the development of drugs is relatively new and challenging because of patients’ personal data and GDPR.

Pros and cons of digital healthcare

Steve talks about the positive and negatives of digital data in healthcare – convenience vs. patient safety

Digital healthcare

Steve talks about the impact of using digital data in healthcare - medical apps help monitor symptoms remotely, patients can now take personal ownership of their own health.

Predictive algorithms

Steve explains how gathered data can lead to creating predictive algorithms, which would estimate patients’ risk of various conditions – this is where the value of digital technology starts to come in.

Digital progress

Steve emphasises that digital technologies help the medical profession make better decisions for patients – it is not about replacing medical physicians, but giving them better tools and techniques. The human-to-human interaction is irreplaceable and will never go away.

Drug development and new technologies

Steve talks about the ‘clash of cultures’ and combining digital technology with the drug development and medical insights

Aptus embraces digital technologies

Steve hopes that the digital progress will enable Aptus to develop quicker and more innovative clinical trials, monitor patients remotely, so they will not have to travel for long distances, and make clinical trials simpler and less invasive.

Full podcast